Loading clinical trials...
Loading clinical trials...
An Open-label Volunteer Study of the Effect of G17DT on the Elevation of Plasma Gastrin Levels After Therapy With a Proton Pump Inhibitor (Omeperazole) in Patients With Treated Stage II/III Colorectal Cancer
Conditions
Interventions
G17DT
Omeprazole
Start Date
April 1, 2000
Primary Completion Date
February 1, 2001
Completion Date
February 1, 2001
Last Updated
August 7, 2015
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
NCT06607458
Lead Sponsor
Cancer Advances Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions